T 611

Drug Profile

T 611

Alternative Names: T 0902611; T 902611

Latest Information Update: 17 Jun 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Tularik
  • Class Antivirals; Small molecules
  • Mechanism of Action Cytomegalovirus replication inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Cytomegalovirus infections

Most Recent Events

  • 17 Jun 2002 Discontinued - Phase-II for Cytomegalovirus infections (PO)
  • 02 Nov 2001 Phase-II clinical trials for Cytomegalovirus infections (PO)
  • 21 Aug 2001 Phase I trials of T 611 have been completed
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top